1. Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study
- Author
-
Aislinn Cook, Laura Ferreras-Antolin, Bethou Adhisivam, Daynia Ballot, James A Berkley, Paola Bernaschi, Cristina G Carvalheiro, Napaporn Chaikittisuk, Yunsheng Chen, Vindana Chibabhai, Shweta Chitkara, Sara Chiurchiu, Elisavet Chorafa, Tran Minh Dien, Angela Dramowski, Samantha Faria de Matos, Jinxing Feng, Daniel Jarovsky, Ravinder Kaur, Warunee Khamjakkaew, Premsak Laoyookhong, Edwin Machanja, Marisa M Mussi-Pinhata, Flavia Namiiro, Gita Natraj, Hakka Naziat, Hoang Thi Bich Ngoc, Claude Ondongo-Ezhet, Kanchana Preedisripipat, Hafizur Rahman, Amy Riddell, Emmanuel Roilides, Neal Russell, Apurba S Sastry, Hannington Baluku Tasimwa, Ji Tongzhen, Jeannette Wadula, Yajuan Wang, Andrew Whitelaw, Dan Wu, Varsha Yadav, Gao Yang, Wolfgang Stohr, Julia Anna Bielicki, Sally Ellis, Adilia Warris, Paul T Heath, and Michael Sharland
- Subjects
Infectious Diseases ,General Medicine - Abstract
Neonatal invasive candidiasis (NIC) has significant morbidity and mortality. Reports have shown a different profile of those neonates affected with NIC and of fluconazole-resistant Candida spp. isolates in low- and middle-income countries (LMICs) compared to high-income countries (HICs). We describe the epidemiology, Candida spp. distribution, treatment, and outcomes of neonates with NIC from LMICs enrolled in a global, prospective, longitudinal, observational cohort study (NeoOBS) of hospitalized infants
- Published
- 2023
- Full Text
- View/download PDF